Mathematical modeling for Hepatitis C Virus (HCV) infection public policy development

Project number: 
04-017
Approval date: 
Thursday, June 2, 2005
Principal Investigator: 
Krajden,Mel
Institution: 
BC Centre for Disease Control (BCCDC)
Funding Agency: 
Canadian Institutes of Health Research(CIHR)
Datasets requested: 
Medical Services Plan (BC Ministry of Health)
Deaths (BC Vital Statistics Agency)
Hospital Separations (BC Ministry of Health)
Mental Health (BC Ministry of Health)
Home and Community Care (BC Ministry of Health)
Consolidation registry (Ministry of Health)
BC Ambulance Service
bc cancer
Research objective: 
Publications: 

Journal Publication

  • Aspinall EJ, Amin J, Goldberg DJ, Grebley J, Hutchinson SJ, Innes H, Janjua NZ, Krajden M, Law M, Yu A, Dore G. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment. J Hepatol 2015;62:269-277
  • Yu A, Spinelli J, Cook D, Buxton J, Krajden M (2013) "Mortality among British Columbians testing for hepatitis C antibody" BMC Public Health Apr 2;13:291. doi: 10.1186/1471-2458-13-291
  • Krajden M, Kuo M, Zagorski B, Yu A, Alvarez M, Krahn M (2010) "Healthcare Costs Associated with Hepatitis C: A Longitudinal Cohort Study" Canadian Journal of Gastroenterology 24(12):717-726
  • Buxton J, Kuo M, Ramji S, Yu A, Krajden M (2010) "Methadone use in relation to hepatitis C virus testing in British Columbia" Canadian Journal of Public Health 101(6):491-494
  • Yu A, Spinelli J, Buxton J, Krajden M (2009) "Mortality among individuals tested for Hepatitis C antibody (anti-HCV) in British Columbia, Canada, 1992-2004" AASLD Annual Conference, Boston, Oct 30-Nov 3  Hepatology 50 4

Academic thesis or dissertation

  • Yu A. Mortality among British Columbians testing for hepatitis C antibody, 1992-2004. 2010. Master of Science Thesis, Health Care and Epidemiology, UBC.
  • Yu Ya-Wen (2010) "Mortality amng British columbians testing for hepatitis C antibody, 1992-2004" MSc diss., University of British Columbia, Health Care & Epidemiology

Presentation of research material (poster/seminar/lecture etc.)

  • Krajden M (2011) "The Burden of HCV in Canada" Canadian Digestive Diseases Week and Canadian Association for the Study of the Liver Meeting, Vancouver, BC February 26
  • Krajden M (2010) "Measuring the Burden of Hepatitis C Virus in BC by Linkage of Laboratory and Administrative Data" BC Children’s Hospital and BC Women’s Hospital & Health Centre, Department of Pathology and Laboratory Medicine Rounds, Vancouver, December 7
  • Yu A, Spinelli J, Buxton J, Krajden M (2010) "Mortality among British Columbians Testing for Hepatitis C Antibody, 1992-2004" Society for Epidemiologic Research annual conference, Seattle, WA, June 23 –26
  • Yu A, Spinelli J, Buxton J, Krajden M (2010) "Mortality among British Columbians Testing for Hepatitis C Antibody, 1992-2004" Manitoba Centre for Health Policy 20th Anniversary Conference, Winnipeg, MB, March 8–9
  • Yu A, Spinelli J, Buxton J, Krajden M (2010) "Mortality among British Columbians Testing for Hepatitis C Antibody, 1992-2004" 5th Annual Public Health Symposium: US/Canada Academic Collaboration in the Pacific Northwest, La Conner, WA, January 8–9
  • Yu A, Spinelli J, Buxton J, Butt G, Alvarez M, Kuo M, Krajden M (2009) "Mortality among British Columbians Testing for Hepatitis C, 1992-2004" Population Data BC conference, Vancouver, BC, May 17 – 18

Conference abstract/presentation

  • Krajden M, Yu A, Buxton J, Spinelli J (2011) "Mortality Among Hepatitis C Antibody Testers in British Columbia" Canadian Digestive Diseases Week and Canadian Association for the Study of the Liver Meeting, Vancouver, BC February 26 – March 1
  • Yu A, Spinelli J, Buxton J, Krajden M (2010) "Mortality among British Columbians Testing for Hepatitis C Antibody, 1992-2004" presented at the Association of Medical Microbiology and Infectious Disease Canada-Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference, Edmonton AB, May
  • Yu A, Spinelli J, Buxton J, Krajden M (2009) "Mortality Among Individuals Tested for Hepatitis C Antibody (anti-HCV) in British Columbia, Canada, 1992-2004" presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA, October 30–November 3
  • Yu A, Spinelli J, Buxton J, Krajden M (2009) "Mortality among British Columbians Testing for Hepatitis C Antibody, 1992-2004" presented at the Canadian Society of Epidemiology and Biostatistics, Ottawa, Ontario, May 23 – 28
  • Krajden, M (2010) "Lessons learned from Linking Hepatitis C Virus (HCV) Laboratory Test and health Administrative Data" prestented at the 1st Canadian HIV/HBV/HCV Co-Infection Research Summit, Toronto, Ont, October 30
  • Krajden, M (2010) "Lessons learned from Linking Hepatitis C Virus (HCV) Laboratory Test and health Administrative Data" prestented at the 1st Canadian HIV/HBV/HCV Co-Infection Research Summit, Toronto, Ont, October 30
  • Chen W, Zogorski B, Krajden M, Heathcote E, Krahn M (2009) "Population-derived estimates of direct medical costs among late-stage Hepatitis C patients with Diabetes" 5th Annual CASL Winter Meeting, Banff, Alberta, Feb 27-Mar 2, Canadian Journal of Gastroenterology 23(Suppl A):P62A
  • Krajden M, Zagorski B, Yu A, Kuo M, Alvarez M, Buxton J, Krahn M (2009) "Hepatitis C-Attributable Health Care Costs Among HCV Testers in BC 1997-2004" 5th Annual CASL Winter Meeting, Banff, Alberta, Feb 27-Mar 2, Canadian Journal of Gastroenterology 23:1549-1554>

Page last revised: December 5, 2017